Provided by Tiger Trade Technology Pte. Ltd.

Biodesix, Inc.

29.11
+3.7214.63%
Volume:158.17K
Turnover:4.45M
Market Cap:307.09M
PE:-9.30
High:30.00
Open:25.70
Low:25.41
Close:25.39
52wk High:30.00
52wk Low:5.26
Shares:10.55M
Float Shares:4.98M
Volume Ratio:0.87
T/O Rate:3.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1298
EPS(LYR):-4.6702
ROE:-540.01%
ROA:-14.05%
PB:33.58
PE(LYR):-6.23

Loading ...

Biodesix Earnings Call Highlights Rapid Growth Path

TIPRANKS
·
Aug 17

Veteran Insider Makes Bold New Bet on Biotech Player

TIPRANKS
·
Aug 14

Biodesix Insider Makes Bold New Move With Fresh Stock Purchase

TIPRANKS
·
Aug 13

Biodesix 10% Owner Jack W. Schuler Reports $669,537 Common Share Purchase

Reuters
·
Aug 13

Biodesix is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 07

Biodesix price target raised to $27 from $26 at H.C. Wainwright

TIPRANKS
·
Aug 07

Analysts Conflicted on These Healthcare Names: Aurora Cannabis (ACB), Biodesix (BDSX) and Insulet (PODD)

TIPRANKS
·
Aug 06

Delcath Systems Q2 Revenue Rises, Beats Estimates

Reuters
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Biodesix (BDSX), Pacific Biosciences (PACB) and Odyssey Therapeutics, Inc. (ODTX)

TIPRANKS
·
Aug 06

Biodesix Q2 2026 earnings: Diagnostic testing growth narrows losses

TradingKey
·
Aug 06

Biodesix Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Biodesix Q2 2026 Net Loss Narrows 37% to $7.3 Million; Revenue Climbs 34% to $26.9 Million

Reuters
·
Aug 06

Biodesix Q2 EPS $(0.71) Beats $(0.91) Estimate, Sales $26.861M Beat $26.026M Estimate

Benzinga Earnings
·
Aug 06

Biodesix Q2 Net Income USD -7.273 Million

Reuters
·
Aug 06

Biodesix: for FY 2026, Co Sees Adj Ebitda Continued Improvement on Path to Profitability

THOMSON REUTERS
·
Aug 06

Biodesix Inc Fy2026 REV View $111.0 Mln

THOMSON REUTERS
·
Aug 06

Biodesix Announces Second Quarter 2026 Results and Highlights

THOMSON REUTERS
·
Aug 06

Biodesix to Present at Canaccord Genuity Annual Growth Conference

Reuters
·
Aug 04

Biodesix Inc Expected to Post a Loss of 90 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Analysts Conflicted on These Healthcare Names: Myriad Genetics (MYGN) and Biodesix (BDSX)

TIPRANKS
·
Aug 01